共 14 条
- [1] Reply to Yu- Wen Hu's Letter to the Editor re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7EUROPEAN UROLOGY, 2016, 70 (06) : E159 - E159Jacksona, William C.Schipper, Matthew J.Feng, Felix Y.
- [3] Re: Andrew J. Stephenson, Michel Bolla, Alberto Briganti, et al. Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy. Eur Urol 2012;61:443-51EUROPEAN UROLOGY, 2012, 62 (06) : E99 - E99Sydes, Matthew R.Vale, ClaireKneebone, AndrewPearse, MariaRichaud, PierreTierney, Jayne F.Parker, Christopher C.
- [4] Re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy. Eur Urol 2016;70:588-96 Testing the Utility of Genomic Scores in the Setting of Recurrent Prostate Cancer After Radical Prostatectomy: We Can Certainly Do BetterEUROPEAN UROLOGY, 2016, 70 (04) : E108 - E109Fossati, NicolaGandaglia, GiorgioBossi, AlbertoMontorsi, FrancescoBriganti, Alberto
- [5] Re: Claude Schulman, Erik Cornel, Vsevolod Matveev, et al. Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND). Eur Urol 2016;69:720-7EUROPEAN UROLOGY, 2017, 71 (02) : E68 - E68Liu, PeihuaLiu, LongfeiZu, Xiongbing
- [6] Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation TherapyEUROPEAN UROLOGY, 2016, 69 (02) : 212 - 213Voog, Justin C.Paulus, RebeccaEfstathiou, Jason A.
- [7] Reply to Nicola Fossati, Giorgio Gandaglia, Alberto Bossi, Francesco Montorsi, Alberto Briganti's Letter to the Editor re: Stephen J. Freedland, Voleak Choeurng, Lauren Howard, et al. Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy After Radical Prostatectomy. Eur Urol 2016;70:588-96EUROPEAN UROLOGY, 2016, 70 (04) : E110 - E111Freedland, Stephen J.Den, Robert B.
- [8] Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017; 71: 1-3EUROPEAN UROLOGY, 2017, 71 (04) : E105 - E106Cronauer, Marcus V.Merseburger, Axel S.Hoda, M. Raschid
- [9] Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019; 75:552-5EUROPEAN UROLOGY, 2019, 76 (03) : E75 - E75Froehner, MichaelThomas, Christian
- [10] Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5 Comparing Apples to Oranges: A Self-fulfilling Prophecy?EUROPEAN UROLOGY, 2019, 75 (05) : E133 - E134Kishan, Amar U.Hall, William A.Spratt, Daniel E.